These observations also reflect translational value of RPS7 as a potential candidate for therapy involving its restoration or reversal of epigenetically silenced state in tumor tissues overexpressing SIRT7 to counter the oncogenic phenotype. The gene discussed is SIRT7; the disease is neoplasm.